[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Persimmon Tree Investments [@PersimmonTI](/creator/twitter/PersimmonTI) on x 9575 followers Created: 2025-05-31 15:20:06 UTC $GILD $xbi Have to hand it to O’Day — that’s quite a chart for Gilead, and congrats on the Trodelvy data at ASCO. Some of his thoughts from Bernstein about M&A: - in no rush to buy anything and can be selective - mid single digit billion range — ex. $CBAY - likely in core areas, such as oncology, liver - late stage or commercial Still think $AKRO is a possibility.  XXXXX engagements  **Related Topics** [$akro](/topic/$akro) [$xbi](/topic/$xbi) [$gild](/topic/$gild) [$psnl](/topic/$psnl) [gilead sciences](/topic/gilead-sciences) [stocks healthcare](/topic/stocks-healthcare) [$cbay](/topic/$cbay) [Post Link](https://x.com/PersimmonTI/status/1928833876719284257)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Persimmon Tree Investments @PersimmonTI on x 9575 followers
Created: 2025-05-31 15:20:06 UTC
$GILD $xbi
Have to hand it to O’Day — that’s quite a chart for Gilead, and congrats on the Trodelvy data at ASCO.
Some of his thoughts from Bernstein about M&A:
Still think $AKRO is a possibility.
XXXXX engagements
Related Topics $akro $xbi $gild $psnl gilead sciences stocks healthcare $cbay
/post/tweet::1928833876719284257